HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Whisker Sells One Millionth Robot and Completes Its $10M USA Manufacturing Expansion
The Litter-Robot 4 was meticulously designed by the Whisker Team, taking more than 20 years of product innovation and experience into consideration.
RedBrick AI Raises US$4.6M
RedBrick AI is building the foundation of healthcare artificial intelligence (AI) with its medical data annotation tools for imagery
Wesper Announces $9.6 Million Series A Round
With FDA clearance and insurance coverage, Wesper has crafted a clinical-grade solution to deliver sleep medicine to the masses.
Ceros Financial Services Arranges $7.5 Million Financing for Wesper
Wesper Home Sleep Lab features a wearable device that monitors sleep conditions For clinical-grade evaluation, analysis and treatment.
NICO Raises $12.5 Million in Oversubscribed Investment Round
NICO is an Indianapolis-based medical device innovator creating a new reality in neurosurgery through its MIS technologies. The company has a strong shareholder base that has invested more than $62 million since its inception in 2007.
Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
Cresilon advises the financing will support the company's efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.
Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
Monteris Medical notes the proceeds of this financing will be used to continue to support the rapid adoption of the NeuroBlate® System, an MR-guided laser ablation system that allows for a minimally invasive surgical alternative to open craniotomies.
FineHeart Awarded €2.5 Mil Grant by the EC Under the Highly Selective EIC Accelerator Program
FineHeart notes this grant has the potential to be followed by an equity investment of up to €15 million by the EIC Fund at the company’s next series C funding round. It will support the industrialization and clinical trials of the ICOMS FLOWMAKER®.
FEMSelect Secures US$9M Series B Financing
Debbie Garner, Co-CEO of FEMSelect, commented, "This investment is a testament to our team and the EnPlace® system. It enables us to expand the medical and patient communities and to serve many more women who are seeking a minimally invasive treatment option. This is a tremendous step forward for the company."